about
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple scle...
Read More
0.36
-0.01
(-2.70%)
468.5K
XNAS Volume
XNAS 28 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
FibroBiologics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..